Cargando…

Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria

BACKGROUND: RTS,S/AS01 has been recommended by WHO for widespread implementation in medium to high malaria transmission settings. Previous analyses have noted lower vaccine efficacies in higher transmission settings, possibly due to the more rapid development of naturally acquired immunity in the co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bell, Griffin J, Gyaase, Stephaney, Goel, Varun, Adu, Bright, Mensah, Benedicta, Essone, Paulin, Dosoo, David, Osei, Musah, Niare, Karamoko, Wiru, Kenneth, Brandt, Katerina, Emch, Michael, Ghansah, Anita, Asante, Kwaku Poku, Mvalo, Tisungane, Agnandji, Selidji Todagbe, Juliano, Jonathan J, Bailey, Jeffrey A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594884/ https://www.ncbi.nlm.nih.gov/pubmed/37872492 http://dx.doi.org/10.1186/s12879-023-08699-7

Ejemplares similares

Malaria Transmission Intensity and Parasitemia during the Three-Dose RTS,S/AS01 Vaccination Series do not Reduce Magnitude of Antibody Response nor Efficacy Against the First Case of Malaria
por: Bell, Griffin J, et al.
Publicado: (2023)

Impacts of Ecology, Parasite Antigenic Variation, and Human Genetics on RTS,S/AS01e Malaria Vaccine Efficacy
por: Bell, Griffin J., et al.
Publicado: (2021)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
por: Gyaase, Stephaney, et al.
Publicado: (2021)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
por: Bell, Griffin J., et al.
Publicado: (2020)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
por: Bejon, Philip, et al.
Publicado: (2013)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
por: Dobaño, Carlota, et al.
Publicado: (2019)

The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01(E) on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants
por: Ajua, Anthony, et al.
Publicado: (2015)

Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children
por: Ubillos, Itziar, et al.
Publicado: (2018)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
por: White, Michael T, et al.
Publicado: (2014)

Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection
por: Macià, Dídac, et al.
Publicado: (2022)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data
por: Warimwe, George M, et al.
Publicado: (2013)

RTS,S: the first malaria vaccine
por: Zavala, Fidel
Publicado: (2022)

The Consequences of Treating Asymptomatic Malaria Parasitemia
por: White, Nicholas J.
Publicado: (2017)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
por: Otieno, Lucas, et al.
Publicado: (2020)

A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
por: Lell, Bertrand, et al.
Publicado: (2009)

Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use
por: Tivura, Mathilda, et al.
Publicado: (2016)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
por: Guerra Mendoza, Yolanda, et al.
Publicado: (2019)

T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
por: Ansong, Daniel, et al.
Publicado: (2011)

Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01(E) malaria vaccine in three regions of Ghana: a qualitative study
por: Grant, Jane, et al.
Publicado: (2022)

Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination
por: Dobaño, Carlota, et al.
Publicado: (2019)

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study
por: Moncunill, Gemma, et al.
Publicado: (2022)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana
por: Dosoo, David Kwame, et al.
Publicado: (2022)

RTS,S Malaria Vaccine and Increased Mortality in Girls
por: Klein, Sabra L., et al.
Publicado: (2016)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
por: Fortpied, Juliette, et al.
Publicado: (2020)

Correction: Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2010)

Dynamics in multiplicity of Plasmodium falciparum infection among children with asymptomatic malaria in central Ghana
por: Botwe, Akua Kyerewaa, et al.
Publicado: (2017)

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
por: White, Michael T, et al.
Publicado: (2015)

Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2020)

Parasitemia Characteristics of Plasmodium vivax Malaria Patients in the Republic of Korea
por: Huh, Ae-Jung, et al.
Publicado: (2011)

The RTS,S malaria vaccine: Journey from conception to recommendation
por: Egbewande, Oluwaseyi Muyiwa
Publicado: (2022)

Prevalence and determinants of caesarean section deliveries in the Kintampo Districts of Ghana
por: Gyaase, Daniel, et al.
Publicado: (2023)

Evidence from a natural experiment that malaria parasitemia is pathogenic in retinopathy-negative cerebral malaria
por: Small, Dylan S, et al.
Publicado: (2017)

Non-malaria fevers in a high malaria endemic area of Ghana
por: Asante, Kwaku Poku, et al.
Publicado: (2016)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study
por: Dosoo, David Kwame, et al.
Publicado: (2019)

Assessing the relationship between gravidity and placental malaria among pregnant women in a high transmission area in Ghana
por: Akinnawo, Ayodele, et al.
Publicado: (2022)

Association between malaria and household air pollution interventions in a predominantly rural area of Ghana
por: Asante, Kwaku Poku, et al.
Publicado: (2023)

Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania
por: Romore, Idda, et al.
Publicado: (2016)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
por: Gosling, Roly, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pcv8ii5vibfm0lbhv58p4bar2b